<DOC>
	<DOCNO>NCT01612598</DOCNO>
	<brief_summary>Patients enrol phase I clinical trial could potentially benefit palliative care concurrently , yet limited evidence available support change care . The primary purpose study test feasibility palliative care intervention ( PCI ) patient participate phase I therapeutic clinical trial</brief_summary>
	<brief_title>Palliative Care Intervention Patients With Solid Tumors Participating Phase I Clinical Trials</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Describe feasibility implement PCI patient phase I clinical trial ( study accrual retention ) . II . Describe initial impact PCI key patient outcome measure ( quality life [ QOL ] , psychological distress , satisfaction communication , symptom intensity , symptom distress , patient satisfaction ) time . OUTLINE : PCI PART I : Patients undergo comprehensive palliative care ( PC ) assessment base baseline data complete goal care discussion . PCI PART II : Following first dose phase I investigational treatment , patient meet interdisciplinary team ( IDT ) , PC recommendation make . This follow two patient educational session cover QOL-related domain , include physical , social , emotional , spiritual well-being . Supportive care referral make base IDT recommendation .</detailed_description>
	<criteria>Patients diagnose solid tumor assess participation phase I clinical trial investigational cancer therapy Able read understand English Ability read and/or understand study protocol requirement , provide write informed consent Patient diagnose hematologic brain cancer</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>